Stable or increased weight was twice as common among pancreatic cancer patients in the atebimetinib + mGnP study, compared to those in a benchmark study
Direct profile
Your Direct account
Manage your avatar, profile name, account email, and usage from one place.
Log in to manage your Direct account profile.
